Mass High Tech
ENTHEOGEN CORP
Is this your company?
Update it or Add a Logo
Logos place your company at the
top of the search results!
About:
Entheogen is developing a drug to treat cluster headaches using a non-hallucinogenic LSD derivative.
Headlines from Mass High Tech about ENTHEOGEN CORP
Print this Listing
Product Information
| Industry Classification | Biopharma/Biotechnology |
| Primary Business Focus | Biotechnology - Pharmaceutical |
Details
| Year Established | 2010 |
| Ownership Type | Private |
| Venture Funding | Subscriber access only |
Contacts
| John Halpern | Co-Founder/Chief Medical Officer | |||
| Torsten Passie | Co-Founder/Chief Scientific Officer | |||
| Ari Mello | Co-Founder/CEO | email available to subscribers |
* Downloads will not contain Personnel E-mail addresses
Search the Directory
Company Overview
| Focus | Biotechnology - Pharmaceutical |
| Location | Boston, MA |
| Website | http://www.entheogencorp.com |
| Revenue | Subscriber access only |
Contact Information
| Address | |
| Phone | 917-267-8916 |
| Subscriber access only | |
| Website | www.entheogencorp.com |
New England Tech Directory
| Browse
| Subscribe
| Advertise
| Networking
| About Us
| Search
| 
RSS Feeds
| 
| Directory License
| Update User Info
| Directory Privacy Policy
| Logout
© 2012 American City Business Journals, Inc. and its licensors. All rights reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of bizjournals.
Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com
Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement and Privacy Policy. About our ads.